Login
Home
Charts
Search
Watchlist
Products

Molbio Diagnostics Ltd

MOLBIO·NSE
₹1,255.00+2.97%Tue, 22 Sept '26 12:30
Industry:Medical Equipment
Indices:

Molbio Diagnostics Ltd

MOLBIO
NSE
₹1,255.00
+2.97%
|Tue, 22 Sept '26 12:30
SOICxStockScans Reports
Industry
Medical Equipment
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹14,465Cr
Close
Close Price
₹1,255.20
Industry
Industry
Medical Equipment
PE
Price To Earnings
86.51
PS
Price To Sales
10.01
Revenue
Revenue
₹1,446Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2025Mar 2026Jun 2026
Revenue
RevenueCr
100561408
Growth YoY
Revenue Growth YoY%
309.6
Expenses
ExpensesCr
115402308
Operating Profit
Operating ProfitCr
-15159101
OPM
OPM%
-15.328.324.6
Other Income
Other IncomeCr
053
Interest Expense
Interest ExpenseCr
41211
Depreciation
DepreciationCr
122017
PBT
PBTCr
-3113276
Tax
TaxCr
-73623
PAT
PATCr
-249653
Growth YoY
PAT Growth YoY%
320.3
NPM
NPM%
-24.017.112.9
EPS
EPS₹
-2.18.15.2
QuarterJun 2025Mar 2026Jun 2026
Revenue
RevenueCr
100561408
Growth YoY
Revenue Growth YoY%
309.6
Expenses
ExpensesCr
115402308
Operating Profit
Operating ProfitCr
-15159101
OPM
OPM%
-15.328.324.6
Other Income
Other IncomeCr
053
Interest Expense
Interest ExpenseCr
41211
Depreciation
DepreciationCr
122017
PBT
PBTCr
-3113276
Tax
TaxCr
-73623
PAT
PATCr
-249653
Growth YoY
PAT Growth YoY%
320.3
NPM
NPM%
-24.017.112.9
EPS
EPS₹
-2.18.15.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
521,2727763328371,0201,446
Growth
Revenue Growth%
2,367.1-39.0-57.2151.622.041.7
Expenses
ExpensesCr
735864062896027581,124
Operating Profit
Operating ProfitCr
-2268637143234262321
OPM
OPM%
-41.853.947.813.028.025.722.2
Other Income
Other IncomeCr
1255-49-67
Interest Expense
Interest ExpenseCr
2236267141833
Depreciation
DepreciationCr
14215532414564
PBT
PBTCr
-5863029610130194231
Tax
TaxCr
-421628113465667
PAT
PATCr
-16468215-384139164
Growth
PAT Growth%
2,973.3-54.0-101.62,525.065.918.4
NPM
NPM%
-31.636.827.7-1.010.013.611.3
EPS
EPS₹
-80.52,313.4974.0-0.19.112.914.8
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
521,2727763328371,0201,446
Growth
Revenue Growth%
2,367.1-39.0-57.2151.622.041.7
Expenses
ExpensesCr
735864062896027581,124
Operating Profit
Operating ProfitCr
-2268637143234262321
OPM
OPM%
-41.853.947.813.028.025.722.2
Other Income
Other IncomeCr
1255-49-67
Interest Expense
Interest ExpenseCr
2236267141833
Depreciation
DepreciationCr
14215532414564
PBT
PBTCr
-5863029610130194231
Tax
TaxCr
-421628113465667
PAT
PATCr
-16468215-384139164
Growth
PAT Growth%
2,973.3-54.0-101.62,525.065.918.4
NPM
NPM%
-31.636.827.7-1.010.013.611.3
EPS
EPS₹
-80.52,313.4974.0-0.19.112.914.8

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
22222211
Reserves
ReservesCr
-1273337087198219661,158
Current Liabilities
Current LiabilitiesCr
206336212258343442557
Non Current Liabilities
Non Current LiabilitiesCr
23417416394953282
Total Liabilities
Total LiabilitiesCr
3158459401,0341,2211,4622,148
Current Assets
Current AssetsCr
1295566346118239301,385
Non Current Assets
Non Current AssetsCr
186289305423398532764
Total Assets
Total AssetsCr
3158459401,0341,2211,4622,148
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
22222211
Reserves
ReservesCr
-1273337087198219661,158
Current Liabilities
Current LiabilitiesCr
206336212258343442557
Non Current Liabilities
Non Current LiabilitiesCr
23417416394953282
Total Liabilities
Total LiabilitiesCr
3158459401,0341,2211,4622,148
Current Assets
Current AssetsCr
1295566346118239301,385
Non Current Assets
Non Current AssetsCr
186289305423398532764
Total Assets
Total AssetsCr
3158459401,0341,2211,4622,148

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-87360101641028750
Investing Cash Flow
Investing Cash FlowCr
-17-145-88-40-45-123-93
Financing Cash Flow
Financing Cash FlowCr
110-204-2218-32-26276
Net Cash Flow
Net Cash FlowCr
511-943-67138233
Free Cash Flow
Free Cash FlowCr
-982263650-72331
CFO To PAT
CFO To PAT%
535.077.046.8-1,861.611.5207.230.7
CFO To EBITDA
CFO To EBITDA%
404.152.527.2148.64.1109.515.7
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-87360101641028750
Investing Cash Flow
Investing Cash FlowCr
-17-145-88-40-45-123-93
Financing Cash Flow
Financing Cash FlowCr
110-204-2218-32-26276
Net Cash Flow
Net Cash FlowCr
511-943-67138233
Free Cash Flow
Free Cash FlowCr
-982263650-72331
CFO To PAT
CFO To PAT%
535.077.046.8-1,861.611.5207.230.7
CFO To EBITDA
CFO To EBITDA%
404.152.527.2148.64.1109.515.7

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
14,465
Price To Earnings
Price To Earnings
86.5
Price To Sales
Price To Sales
10.0
Price To Book
Price To Book
10.6
EV To EBITDA
EV To EBITDA
46.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.869.162.251.055.654.355.855.8
OPM
OPM%
-41.853.947.813.028.025.722.222.2
NPM
NPM%
-31.636.827.7-1.010.013.611.311.3
ROCE
ROCE%
-12.9111.839.21.914.319.016.316.3
ROE
ROE%
13.0139.730.3-0.510.214.314.014.0
ROA
ROA%
-5.255.322.9-0.36.89.57.67.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
14,465
Price To Earnings
Price To Earnings
86.5
Price To Sales
Price To Sales
10.0
Price To Book
Price To Book
10.6
EV To EBITDA
EV To EBITDA
46.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.869.162.251.055.654.355.855.8
OPM
OPM%
-41.853.947.813.028.025.722.222.2
NPM
NPM%
-31.636.827.7-1.010.013.611.311.3
ROCE
ROCE%
-12.9111.839.21.914.319.016.316.3
ROE
ROE%
13.0139.730.3-0.510.214.314.014.0
ROA
ROA%
-5.255.322.9-0.36.89.57.67.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Molbio Diagnostics Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/n2poqb6bxqrscudo2d9b1mzd.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/9hwdmqthj0vhw8w750lzjtfg.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/99asuec0ptn84fidkgkuzn70.pdf

Concall Transcript Summaries — Molbio Diagnostics Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AMOLBIO/transcript-notes/202606/n2poqb6bxqrscudo2d9b1mzd.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies